Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Researchers Using Thermo Fisher Mass Spec in Proteome Studies

NEW YORK (GenomeWeb News) – Canadian researchers are using Thermo Fisher Scientific’s LTQ Orbitrap ion trap mass spectrometer in studies of protein interactions and their involvement in diseases.
 
Thermo Fisher said today that the Institut de Recherches Cliniques in Montreal is using the firm’s mass spectrometry technology in its efforts to develop a more complete understanding of the human proteome through the Human Proteotheque Initiative.
 
The HuPI initiative, which includes collaborators at various universities and research centers, aims to develop maps of the human proteome that will form an atlas that “should become a valuable resource for scientists in basic biological and biomedical research because enzymes and other proteins carry most of the biological functions required for cell growth and differentiation.”
 
These maps will eventually be made publicly available, the company said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.